Cryo-Cell International Inc (CCEL)
7.15
-0.22
(-2.99%)
USD |
NYAM |
Nov 05, 16:00
7.15
0.00 (0.00%)
After-Hours: 18:51
Cryo-Cell International Revenue (Quarterly): 8.067M for Aug. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 8.067M |
| May 31, 2024 | 8.043M |
| February 29, 2024 | 7.852M |
| November 30, 2023 | 7.877M |
| August 31, 2023 | 7.870M |
| May 31, 2023 | 7.773M |
| February 28, 2023 | 7.824M |
| November 30, 2022 | 7.764M |
| August 31, 2022 | 7.681M |
| May 31, 2022 | 7.633M |
| February 28, 2022 | 7.258M |
| November 30, 2021 | 7.315M |
| August 31, 2021 | 7.504M |
| May 31, 2021 | 7.205M |
| February 28, 2021 | 6.861M |
| November 30, 2020 | 7.541M |
| August 31, 2020 | 8.114M |
| May 31, 2020 | 7.872M |
| February 29, 2020 | 7.621M |
| November 30, 2019 | 7.970M |
| August 31, 2019 | 8.223M |
| May 31, 2019 | 8.128M |
| February 28, 2019 | 7.495M |
| November 30, 2018 | 8.594M |
| August 31, 2018 | 7.871M |
| Date | Value |
|---|---|
| May 31, 2018 | 6.526M |
| February 28, 2018 | 6.228M |
| November 30, 2017 | 6.475M |
| August 31, 2017 | 6.896M |
| May 31, 2017 | 6.237M |
| February 28, 2017 | 5.777M |
| November 30, 2016 | 5.871M |
| August 31, 2016 | 6.332M |
| May 31, 2016 | 5.773M |
| February 29, 2016 | 5.152M |
| November 30, 2015 | 5.798M |
| August 31, 2015 | 5.436M |
| May 31, 2015 | 5.014M |
| February 28, 2015 | 4.843M |
| November 30, 2014 | 4.975M |
| August 31, 2014 | 4.938M |
| May 31, 2014 | 4.893M |
| February 28, 2014 | 5.320M |
| November 30, 2013 | 4.706M |
| August 31, 2013 | 4.830M |
| May 31, 2013 | 4.859M |
| February 28, 2013 | 4.600M |
| November 30, 2012 | 4.823M |
| August 31, 2012 | 4.542M |
| May 31, 2012 | 4.426M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
6.861M
Minimum
Feb 2021
8.114M
Maximum
Aug 2020
7.682M
Average
7.768M
Median
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 7.056M |
| Novo Integrated Sciences Inc | 3.152M |
| Astrana Health Inc | 486.26M |
| P3 Health Partners Inc | 379.16M |
| Biote Corp | 49.17M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.052M |
| Total Expenses (Quarterly) | 6.664M |
| EPS Diluted (Quarterly) | 0.13 |
| Enterprise Value | 68.02M |
| Gross Profit Margin (Quarterly) | 73.65% |
| Profit Margin (Quarterly) | 13.04% |
| Earnings Yield | -15.01% |
| Operating Earnings Yield | 6.11% |
| Normalized Earnings Yield | 2.620 |